Recommended.co.nz | Guide2.co.nz | Voxy.co.nz | Gimme.co.nz
Homepage | login or create an account

biotechnology

Genesis Research Close To RNA Research Deal

Genesis Research Close To RNA Research Deal
Wellington, July 1 NZPA - Genesis Research and Development says it is confident it can close a deal with an overseas investor to help fund its research into gene silencing technology.

Govt Rules Out Further Assessment Of Milk Safety

By Kent Atkinson of NZPA Wellington, July 1 NZPA - The Government says it won't honour the previous administration's plan to convene a group of experts to discuss the safety of A2 milk, relative to "ordinary" A1 milk.

`Stunning' Progress Reported For Diabetes Treatment Trials

`Stunning' Progress Reported For Diabetes Treatment Trials
Wellington, June 17 NZPA - Auckland-based biotechnology company Living Cell Technologies is to open a $2.5 million high-tech pig breeding facility for up to 50 animals in Invercargill next month.

Pfizer Multinational Makes Move On Takeover Target Wyeth In NZ

Pfizer Multinational Makes Move On Takeover Target Wyeth In NZ
Wellington, June 10 NZPA - Pharmaceutical multinational Pfizer Inc has applied to the Commerce Commission for clearance to take over rival drug company Wyeth Corp. Pfizer sells human and animal health products through its local subsidiary, Pfizer New Zealand Ltd.

PharmaZen Achieves Turnaround In 2008

PharmaZen Achieves Turnaround In 2008
Wellington, April 14 NZPA - Christchurch-based biotechnology company PharmaZen achieved a turnaround last year to a pre-tax surplus of $442,822, saying it capitalised on groundwork done in previous years.

Bioethics Council Says Its Work Is Not Duplicated

Bioethics Council Says Its Work Is Not Duplicated
Wellington, March 16 NZPA - The Bioethics Council sent out a swansong press release thanking its supporters today but also having a dig at the Government for shutting it down.

Genesis Research Says Unpaid Debt Leaves It Without Enough Cash

Genesis Research Says Unpaid Debt Leaves It Without Enough Cash
Wellington, Feb 23 NZPA - Biotech company Genesis Research and Development Ltd has posted a loss of $7.5 million, bigger than expected for the year to December 30, 2008, apparently because it has not been fully paid for shares it sold in a willow biofuel project.

New Zealand Sharemarket Remains Positive On Open

New Zealand Sharemarket Remains Positive On Open
Wellington, Jan 14 NZPA - The New Zealand sharemarket remained positive when it opened this morning. The benchmark NZSX-50 index was up 3.481 points, or 0.125 percent, to 2778.123 at 10.15am.

$2m Payment To Biotech Co Deferred For Second Time

$2m Payment To Biotech Co Deferred For Second Time
Wellington, Jan 9 NZPA - A $2 million payment to biotechnology company Genesis Research and Development Corp for its BioJoule shares has been delayed for a second time.

Labour Party: Sustainable Economy Policy

A sustainable economy will be built on the following policy foundations:

Credit Card Comparison TablesCompare Credit Cards - Independent interest rate and fees comparisons for New Zealand banks.